SecBot SecBot
8-K ·Filed Apr 7, 2026

RWAYI

Runway Growth Finance Corp.
BULLISH
Impact 8/10
Horizonweeks Processed6mo ago SEC0001193125-26-144599
8-K material event: Items 2.01
Actionable Insight ▲ Bullish

The acquisition significantly scales Runway's platform and diversifies its portfolio into healthcare/life sciences. The $30 million debt assumption is manageable given the $1.2 billion pro forma asset base. The advisor's $9 million cash contribution signals strong confidence in the combined entity's prospects. Monitor integration progress and whether the expected accretion to net investment income materializes.

DirectionBullish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
RWAYI ▼ -2.11% at T+60d
LONG call ✗ call lost -2.11% · α vs SPY -15.38% · entry $25.14 → $24.61
Entry = T+0 close
Apr 7, 2026
via day close
T+1d
+0.04%
call +0.04% · α -2.50%
$25.15
settled 7mo ago
T+5d
+1.19%
call +1.19% · α -4.14%
$25.44
settled 7mo ago
T+20d
+0.76%
call +0.76% · α -9.03%
$25.33
settled 6mo ago
T+60d
-2.11%
call -2.11% · α -15.38%
$24.61
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Runway Growth Finance Corp. completed its acquisition of SWK Holdings Corporation for $249 million, assuming $30 million in SWK's 9.00% Senior Notes due 2027, while announcing first-quarter portfolio activity including $17.6 million in new investments. The deal expands Runway's healthcare exposure and scales its platform to $1.2 billion in pro forma assets.

Key Facts

  • Completed acquisition of SWK Holdings Corporation for $249 million (combination of $173.5 million cash and $75.5 million in Runway shares)
  • Assumed $30,000,000 in aggregate principal amount of SWK's 9.00% Senior Notes due 2027
  • Pro forma balance sheet now $1.2 billion in total assets
  • Healthcare and life sciences exposure increased to 32% of portfolio from 14%
  • Completed four investments totaling $17.6 million in Q1 2026
  • Advisor contributed $9.0 million in cash as additional consideration

Financial Impact

Acquisition valued at $249 million with $30 million in assumed debt; $9 million cash contribution from advisor; $17.6 million in new portfolio investments

total assetsdebtportfolio compositionhealthcare exposure

Risk Factors

  • Integration risk from combining two specialty finance platforms
  • Concentration risk in healthcare/life sciences now at 32% of portfolio
  • Execution risk in realizing projected accretion to net investment income

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-144599
Document: 0001193125-26-144599-index.html0001193125-26-144599
Document: 0001193125-26-144599.txt0001193125-26-144599
3 reports for RWAYI
Performance horizon
Filters
Rows
Reports for RWAYI — sortable, filterable
TypeNow
May 29, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$24.70 $24.82▲ +0.49%▼ −0.75%$24.85 (+0.61%)
Apr 13, 2026
28w ago
3
NEUTRAL ★ 4/10
$25.44 $24.73▼ −2.79%▼ −11.31%$24.85 (−2.32%)
Apr 7, 2026
29w ago
8-K
BULLISH ★ 8/10
$25.14 $24.61▼ −2.11%▼ −15.38%$24.85 (−1.15%)
Showing 3 of 3

US Market Status

Market Closed — Opens Thu (13h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 7, 2026